NYSE:ANIXITUS Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ITUS Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.28 0.00 (0.00 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's Range$2.09Now: $2.28▼$2.3150-Day Range$1.71MA: $1.94▼$2.3252-Week Range$1.33Now: $2.28▼$5.45Volume148,750 shsAverage Volume166,417 shsMarket Capitalization$47.90 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesHeadlinesSocial Media Anixa Biosciences, Inc. engages in the development, acquisition and licensing emerging technology in the field of biotechnology. It focuses on platform called Cchek, a series of inexpensive non-invasive blood tests for the early detection of cancer, which is based on the body's immunological response to the presence of a malignancy. The company was founded on November 5, 1982 and is headquartered San Jose, CA.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingITUS has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.25, ITUS has a potential upside of 261.8% from its current price of $2.28.Amount of Analyst CoverageITUS has only been the subject of 1 research reports in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesITUS has received 52 “outperform” votes. (Add your “outperform” vote.)Underperform VotesITUS has received 60 “underperform” votes. (Add your “underperform” vote.)Community SentimentITUS has received 53.57% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ITUS and other stocks. Vote “Outperform” if you believe ANIX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ANIX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldITUS does not currently pay a dividend.Dividend GrowthITUS does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ITUS insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,294.00 in company stock and sold $0.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.76 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Computer Peripherals Sub-IndustryN/A SectorElectronic Technology Current SymbolNYSE:ANIX Previous Symbol CUSIPN/A CIKN/A WebN/A Phone(408) 708-9808Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares21,007,000Market Cap$47.90 million Next Earnings Date6/9/2020 (Estimated) OptionableNot Optionable ANIX Rates by TradingView Receive ANIX News and Ratings via Email Sign-up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. ITUS (NYSE:ANIX) Frequently Asked Questions How has ITUS's stock been impacted by COVID-19 (Coronavirus)? ITUS's stock was trading at $2.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ANIX shares have increased by 10.1% and is now trading at $2.28. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of ITUS? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ITUS in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ITUS. When is ITUS's next earnings date? ITUS is scheduled to release its next quarterly earnings announcement on Tuesday, June 9th 2020. View our earnings forecast for ITUS. How were ITUS's earnings last quarter? ITUS Corporation (NYSE:ANIX) issued its quarterly earnings data on Monday, March, 9th. The company reported ($0.13) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.13). View ITUS's earnings history. What price target have analysts set for ANIX? 2 brokerages have issued 1 year price objectives for ITUS's stock. Their forecasts range from $8.00 to $8.50. On average, they anticipate ITUS's share price to reach $8.25 in the next twelve months. This suggests a possible upside of 261.8% from the stock's current price. View analysts' price targets for ITUS. Has ITUS been receiving favorable news coverage? Media coverage about ANIX stock has trended negative on Monday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ITUS earned a media sentiment score of -2.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutITUS. Who are some of ITUS's key competitors? Some companies that are related to ITUS include Cobham (CBHMF), HEICOCorp . (HEI/A), Infineon Technologies (IFNNF), Kure Technologies (UBSBF), Lenovo Group (LNVGF), Onelife Technologies (OLMM), Telit Communications (TTCNF), Xenonics (XNNH) and ZTE/Shs H Vtg 1.00 (ZTCOF). View all competitors. What other stocks do shareholders of ITUS own? Based on aggregate information from My MarketBeat watchlists, some companies that other ITUS investors own include Bank of America (BAC), Gilead Sciences (GILD), Applied DNA Sciences (APDN), Digital Turbine (APPS), Alibaba Group (BABA), AbbVie (ABBV), Blink Charging (BLNK), Commercial Metals (CMC), IBM (IBM) and Advanced Micro Devices (AMD). Who are ITUS's key executives? ITUS's management team includes the following people: Amit Kumar, Executive Chairman, President & CEOMichael J. Catelani, Chief Operating & Financial OfficerJohn A. Roop, Senior Vice President-EngineeringAnthony Campisi, Vice President-Engineering What is ITUS's stock symbol? ITUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANIX." How do I buy shares of ITUS? Shares of ANIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ITUS's stock price today? One share of ANIX stock can currently be purchased for approximately $2.28. How big of a company is ITUS? ITUS has a market capitalization of $47.90 million. How can I contact ITUS? The company can be reached via phone at (408) 708-9808. This page was last updated on 6/1/2020 by MarketBeat.com Staff
